Multimedia
View More
Hear an expert overview of emerging options for prevention and outpatient treatment of COVID-19, and learn the rationale for increased federal investment into developing oral antivirals against SARS-CoV-2.
Arthur Kim, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: August 25, 2021
Expired:
August 24, 2022
Review compelling new data on the use of monoclonal antibodies as postexposure prophylaxis for persons exposed to SARS-Cov-2 and as outpatient therapy and inpatient therapy for persons with COVID-19.
Lynora Saxinger, MD, FRCPC, CTropMed
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: December 10, 2021
Expired:
December 9, 2022
Join Arthur Kim, MD, as he discusses exciting data supporting the implementation of oral and IV antiviral medications for postexposure prophylaxis and treatment of SARS-CoV-2.
Arthur Kim, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: February 2, 2022
Expired:
February 1, 2023
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.